期刊文献+

宫颈癌患者人乳头瘤病毒感染分布情况及多重感染与临床病理特征的关系 被引量:15

The Distribution of Human Papillomavirus Infection and the Relationship between Multiple Infection and Clinicopathological Characteristics in Patients with Cervical Cancer
原文传递
导出
摘要 目的:研究宫颈癌患者人乳头瘤病毒(HPV)感染的分布情况及多重感染与临床病理特征的关系。方法:选择2015年1月-2018年1月期间我院收治的118例宫颈癌患者,根据患者宫颈癌的病变程度分为I期组(n=21)、II期组(n=46)、III期组(n=49)、IV期组(n=2)。所有患者均进行HPV分型检测,比较不同程度的宫颈癌患者的HPV感染情况,分析不同宫颈癌病变程度患者的多重感染和临床病理特征关系。结果:118例患者中有97例患者感染了HPV,感染率为82.20%,且II期组、III期组、IV期组患者HPV感染率高于I期组(P<0.05)。II期组、III期组、IV期组患者一重感染率低于I期组,IV期组二重感染率低于I期组,II期组、III期组、IV期组患者多重感染率高于I期组,且IV期组多重感染率高于II期组、III期组(P<0.05)。多重感染患者类型有多种,其中尤以HPV16+18+53型最多,占比49.05%,其次是HPV16+18+68型感染,占比32.07%,HPV16+53+58型感染,占比13.21%。年龄在50岁以上、分期为III-IV期、鳞癌、淋巴结转移的患者HPV多重感染率更高(P<0.05)。结论:HPV多重感染与宫颈癌病变程度和临床病理特征均有联系,对年龄较大且HPV多重感染的宫颈癌患者进行筛查,预防病情恶化。 Objective: To investigate the distribution of human papillomavirus(HPV) and the relationship between multiple infection and clinicopathological characteristics in patients with cervical cancer. Methods: 118 cases of cervical cancer who were treated in our hospital from January 2015 to January 2018 were selected. According to the degree of cervical cancer,they were divided into I stage group(n=21),II stage group(n=46),III stage group(n=49),IV stage group(n=2). All patients were detected by HPV typing,the HPV infection of cervical cancer patients in different degrees were compared,the relationship between multiple infections and clinicopathological characteristics of patients with different degrees of cervical cancer were analyzed. Results: Among the 118 patients,97 patients were infected with HPV,the infection rate was 82.20%,the HPV infection rate in II stage group,III stage group and IV stage group was higher than that of I stage group(P〈0.05). The single infection rate of II stage group,III stage group and IV stage group was lower than that of I stage group,the double infection rate of IV stage group was lower than that of I stage group. The multiple infection rate in II stage group,III stage group and IV stage group were higher than that in I stage group,the multiple infection rate in IV stage group was higher than that in II stage group and III stage group(P〈0.05). There were many types of multiple infection patients,most of them were HPV16+18+53 type,accounting for 49.05%,the second was type HPV16+18+68 infection,which accounted for 32.07%,type HPV16+53+58 infection,accounting for 13.21%,patients with age over 50 years,stage III-IV,squamous cell carcinoma and lymph node metastasis had higher HPV multiple infection rate(P〈0.05). Conclusion: HPV multiple infection is associated with the degree and clinicopathological features of cervical cancer,screening for patients with older and multiple HPV infections to prevent the deterioration of the disease.
作者 李松 刘君丽 余超 孙余 丁春雨 LI Song;LIU Jun-li;YU Chao;SUN Yu;DING Chun-yu(Department of Laboratory Medicine,Union Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology,Wuhan,Hubei,430022,China)
出处 《现代生物医学进展》 CAS 2018年第16期3062-3065,3045,共5页 Progress in Modern Biomedicine
基金 湖北省自然科学基金项目(2014CFB2037)
关键词 宫颈癌 人乳头瘤病毒 多重感染 临床病理特征 关系 Cervical cancer Human papillomavirus Multiple infection Clinicopathological characteristics Relationship
  • 相关文献

参考文献2

二级参考文献25

  • 1Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium [J]. Int J Gynaecol Obstet, 2009, 105 (2): 103-104.
  • 2Denny L.Cervical cancer prevention:new opportunities for primary and secondary prevention in the 21st century [J]. Int J Gynecol Obstet, 2012, 119(Suppl 1 ): 80-84.
  • 3Alam MS, Ali A, Mehdi SJ, et al. HPV typing and its relation with apoptosis in cervical carcinoma from Indian population [J]. Tumour Biol, 2012, 33( 1 ): 17-22.
  • 4KoliopoUlos G, Valasoulis G, Zilakou E.An update review on HPV testing methods for cervical neoplasia [J]. Expert Opinion on Medical Diagnostics, 2009, 3(2): 123-13 1.
  • 5Halfon P, Benmoum D, Khiri H, et al. Comparison of the clinical performance of carcinogenic HPV typing of the Linear Array and Pap- illocheck HPV-screening assay[J]. J Clin Virol, 2010, 47( 1 ): 38-42.
  • 6Ramogola-Masire D, MeG ruth CM, Barnhart KT, et al. Subtype Distribution of human papillomavirus in HIV-infected women with cervical intraepithelial neoplasia stages 2 and 3 in Botswana [J]. Int J Gyneeol Pathol, 2011, 30(6): 591-596.
  • 7Kjaer SK, Breugelmans G, Munk C, et al. Population-based prevalenc- e, type- and age-specific distribution of HPVin women before introducti- on of an HPV-vaccination program in Denmark[J]. Int J Cancer, 2008, 123(8): 1864-1870.
  • 8Sanchez GI, Kleter B, Gheit T, et al. Clinical evaluation of polymerase chain reaction reverse hybridization assay for detection and identifica- tion of human papillomavirus type 16 variants [J]. J Clin Virol, 2011, 51(3): 165-169.
  • 9Abdelmutti N, Hoffman-Goetz L. Risk Messages about I-IPV, Cervical Cancer, and the HPV Vaccine Gardasil in North American News Magazines[J]. J Cancer Educ, 2010, 25(3): 451-456.
  • 10Erica R, Heitmann, Diane M, et al. Prophylactic HPV Vaccines and Prevention of Cervical Intraepithelial Neoplasia[J]. Current Obstetrics and Gynecology Reports, 2012, 1 (3): 95-105.

共引文献102

同被引文献149

引证文献15

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部